Noteworthy, no statistically significant difference was observed between the two treated groups, suggesting that despite the fact that ICOVIR5-TK-L presents a reduced ability to replicate it can induce, when applied in combination with GCV, a similar antitumor effect as a replicative adenovirus without tumor specificity. Here, TXK is linked to neoplasm.